Aripiprazole Lauroxil (Aristada, Aristada Initio)

FDA Approved 2015

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published December 1, 2025•Updated December 1, 2025•Reviewed December 1, 2025

Clinical summary for Aripiprazole Lauroxil (Aristada, Aristada Initio): Aristada is a long-acting shot version of Abilify (aripiprazole) used to treat schizophrenia. Once you’ve tried and tolerated oral aripiprazole, you can switch to a shot in the arm or buttock given about once a month (or every 6–8 weeks, depending on the dose). A one-time loading shot (Aristada Initio) plus a single big oral dose is sometimes used to get you to steady levels quickly. It is **not** approved for dementia-related behavior problems in older adults and has a boxed warning for higher risk of death in that group.

What It's Used For

Aripiprazole lauroxil (Aristada) is a long-acting injectable antipsychotic used for ongoing treatment of schizophrenia in adults. It is **not** used to treat dementia-related psychosis and carries a boxed warning for increased mortality in elderly patients with dementia.

Primary Indications

Schizophrenia: Long-term maintenance treatment after establishing tolerability to oral aripiprazoleRelapse prevention: Helps maintain stable symptom control by avoiding missed daily dosesAdherence support: Monthly or every-6-to-8-week injections can be easier for some people than taking daily pills

Off-Label Uses

Other psychotic disorders in consultation with a psychiatrist (not FDA-approved)Patients with poor adherence to oral antipsychotics where a long-acting injectable is preferred

What People Feel

People’s experiences vary, but these are common themes reported with Aristada:

Stability & Symptom Control

"It helped keep my voices and paranoia in check between visits."

How Fast It Works

Because Aristada is a long-acting injection, it doesn’t work instantly like a pill—but the combination strategies with Aristada Initio and/or oral aripiprazole are designed to get you to effective levels within a few days.

Before starting

You first take oral aripiprazole to make sure you tolerate it.

Aristada Initio

One-time 675 mg IM dose reaches the bloodstream the same day; with a single 30 mg oral dose, clinically helpful levels are reached in about 4 days.

Aristada (maintenance)

Without Initio, it typically takes ~5–6 days after the first injection (plus overlap with oral aripiprazole) to reach therapeutic levels.

Duration

Each Aristada injection is designed to last about 4–8 weeks depending on the dose (monthly, every 6 weeks, or every 2 months).

Very long half-life

The prolonged half-life (~2 months) means levels decline slowly if treatment is stopped.

How Well It Works

Clinical trials show that long-acting aripiprazole injections help maintain symptom control and reduce relapse risk in schizophrenia when used consistently as part of a treatment plan.

In clinical studies, long-acting aripiprazole formulations reduce relapse risk and help maintain symptom control in adults with schizophrenia who respond to aripiprazole. The long-acting injection is often chosen when daily pill adherence is difficult or when stable blood levels are desired.

Source:

Critical Safety Information

Increased risk of death in elderly patients with dementia-related psychosis. Aripiprazole lauroxil is **not approved** for dementia-related psychosis.

→If you or your family notice new or intense urges (gambling, sex, shopping, eating) that are out of character, contact your prescriber promptly.
→Tell your clinician right away if you have high fever, severe muscle stiffness, confusion, or fast heartbeat—these can be signs of neuroleptic malignant syndrome.
→Report any uncontrollable movements of the face, tongue, or body (chewing, lip-smacking, tongue sticking out) immediately.
→Get regular blood tests for blood sugar, cholesterol, and sometimes blood counts as recommended.
→Stand up slowly from sitting or lying down to reduce dizziness and prevent falls.
→Tell every provider you see (including dentists) that you receive Aristada, and carry your injection card if given one.

Side Effects

Most common side effects include akathisia (restlessness), injection-site reactions, weight gain, and insomnia. Serious but less common risks include neuroleptic malignant syndrome, tardive dyskinesia, blood dyscrasias, and impulse control problems.

Common Things People Notice

Restlessness or feeling like you need to keep moving (akathisia)
Stiffness, slower movements, or tremor (parkinsonism / EPS)
Weight gain and possible changes in blood sugar and cholesterol
Injection site pain, redness, or swelling
Trouble sleeping (insomnia) or feeling sleepy/dizzy

Common Side Effects

≈11%

Akathisia (inner restlessness)— A strong urge to move, pacing, or feeling like you “can’t sit still.” This can be very uncomfortable but is often treatable by adjusting the dose or adding a medication.

≈5–7% (parkinsonism ~4%, dystonia ~2%)

Extrapyramidal symptoms (EPS)— Stiffness, tremor, slowed movements, or muscle spasms. Risk may be higher at higher doses and in younger males. Contact your provider if you notice these signs.

Pain 3–4%; reaction 4–5%

Injection-site reactions— Soreness, redness, or swelling where the shot was given. Usually mild and lasts a few days.

≥7% weight gain in about 9–10% of patients

Weight gain— Weight gain with aripiprazole LAI is generally modest compared to many other antipsychotics, but healthy eating and activity plus regular weight checks are important.

Insomnia 3–4%; headache ~5%; restlessness ~3%

Insomnia / Headache / Restlessness— Trouble sleeping, feeling keyed up, or having headaches may occur, especially early in treatment or after dose changes.

1–2%

CK elevation— Labs may show higher muscle enzyme levels (CK), usually without symptoms. Severe muscle pain, weakness, or dark urine should be reported right away.

⚠️ Serious Side Effects

Neuroleptic malignant syndrome: fever, muscle rigidity, confusion, autonomic instability (medical emergency).
Tardive dyskinesia: potentially irreversible abnormal movements of face, tongue, or body.
Severe impulse control disorders: compulsive gambling, shopping, eating, or hypersexuality.
Severe neutropenia or agranulocytosis: very low white blood cell count with infection risk (fever, chills, sore throat).
Serious metabolic effects: marked hyperglycemia or diabetic ketoacidosis.
Cerebrovascular events in older adults with dementia-related psychosis (stroke, TIA).
Orthostatic hypotension leading to falls, fractures, or syncope.
Seizures in susceptible individuals.

Critical Drug Interactions

Aripiprazole lauroxil is a prodrug of aripiprazole, which is metabolized primarily by CYP2D6 and CYP3A4. Strong inhibitors or inducers can significantly change active drug levels.

With: Strong CYP2D6 or CYP3A4 inhibitors (eg, fluoxetine, paroxetine, quinidine, clarithromycin, some azoles, some HIV protease inhibitors)

Risk: Increased active aripiprazole exposure and side effect risk (akathisia, EPS, sedation, impulse control issues).

Action: Dose reduction is usually required (eg, decrease Aristada to the next lower strength if a strong CYP2D6 or CYP3A4 inhibitor is used for >14 days; max 441 mg if both pathways strongly inhibited or in CYP2D6 poor metabolizers).

With: Strong CYP3A4 inducers (eg, carbamazepine, rifampin, phenytoin, St. John’s Wort)

Risk: Lower aripiprazole levels and loss of effect; risk of relapse.

Action: May require dose increase (eg, from 441 mg to 662 mg if on a strong inducer for >14 days) or reconsideration of either the inducer or antipsychotic regimen.

With: Other antipsychotics and dopamine agonists (eg, levodopa, pramipexole)

Risk: Increased EPS and NMS risk with multiple antipsychotics; reduced benefit of dopamine agonists used in Parkinson disease.

Action: Avoid unnecessary antipsychotic polypharmacy. If Parkinson disease is present, prefer antipsychotics with less D2 blockade (eg, clozapine or quetiapine) or pimavanserin when appropriate.

With: Other CNS depressants (benzodiazepines, sedating antihistamines, opioids, alcohol)

Risk: Additive sedation, dizziness, falls, and cognitive impairment.

Action: Use with caution, minimize doses, and avoid alcohol. Monitor closely for sedation and falls.

With: Agents that lower seizure threshold (eg, bupropion, tramadol, many antipsychotics, some antidepressants)

Risk: Higher seizure risk.

Action: Use caution in patients with seizure risk factors; monitor and consider alternatives if possible.

With: Antidiabetic agents

Risk: Hyperglycemia from antipsychotic can worsen glucose control, reducing the effectiveness of diabetes medications.

Action: Monitor blood sugar closely and adjust diabetes medications as needed.

Stopping or Switching

Because Aristada is a long-acting injection with a very long half-life, the drug leaves your system slowly over weeks to months. Classic "tapering" is less relevant than with oral medications, but careful planning is still essential.

Key Points

Discontinuation: Gradual oral taper is usually **not** needed when stopping the LAI itself because drug levels fall slowly on their own.
Monitoring: If Aristada is stopped or switched, monitor closely for early warning signs of relapse (sleep changes, suspiciousness, social withdrawal, odd behavior).
Switching antipsychotics: Strategies include cross-titration (gradually reducing Aristada while building up a new agent) or adding the new medication while Aristada levels are still present and then letting Aristada “wash out.” This should be guided by a psychiatrist.
Missed doses: A late or missed injection may require supplemental Aristada Initio and/or oral aripiprazole depending on how overdue the dose is.
Relapse risk: Stopping long-acting antipsychotic treatment increases relapse risk; discuss any desire to stop with the prescriber and plan a careful strategy.

Dosing Information

Adult Dosing

schizophrenia initial with initio: Aristada Initio 675 mg IM once + 30 mg oral aripiprazole on the same day, then first Aristada maintenance injection (dose based on prior oral aripiprazole) either the same day or within 10 days.

schizophrenia initial 21day overlap: Start Aristada at the dose equivalent to the patient’s oral aripiprazole and continue oral aripiprazole for 21 days after the first Aristada injection.

dose conversions: Oral aripiprazole 10 mg/day → 441 mg Aristada every month; 15 mg/day → 662 mg every month or 882 mg every 6 weeks or 1,064 mg every 2 months; ≥20 mg/day → 882 mg every month.

maintenance: Use the same Aristada dose and interval as the initial maintenance dose (monthly, every 6 weeks, or every 2 months). Adjust based on response and tolerability.

max dose: Maximum 882 mg every month or 1,064 mg every 2 months.

missed doses: If injections are late, supplemental oral aripiprazole and/or Aristada Initio may be needed depending on how long it has been (eg, no supplement if 441 mg dose is ≤6 weeks late; more complex strategies if >7 weeks).

renal: No dosage adjustment required in kidney impairment.

hepatic: No dosage adjustment required in liver impairment, but monitor carefully.

elderly: Use extra caution. Avoid for dementia-related behaviors unless benefits clearly outweigh risks and non-drug strategies have failed.

Simple Explanation

You first prove you tolerate aripiprazole pills. Then you can switch to a shot (Aristada) given every 4–8 weeks. A one-time loading shot (Aristada Initio) plus a big oral dose can get you to steady levels faster at the very beginning or after long gaps between injections.

Pregnancy, Breastfeeding, Special Groups

As with other antipsychotics, aripiprazole lauroxil requires careful risk–benefit discussion in pregnancy, breastfeeding, and medically complex patients.

👶Pregnancy

Aripiprazole crosses the placenta. Late-pregnancy exposure to antipsychotics can cause newborn extrapyramidal or withdrawal symptoms (respiratory distress, feeding problems, irritability). When possible, use the lowest effective dose and avoid polypharmacy. Do not stop effective treatment abruptly in pregnancy without expert guidance.

🤱Breastfeeding

Aripiprazole is present in breast milk and may reduce milk supply. Infants should be monitored for sedation, poor feeding, and weight gain issues. Decisions about breastfeeding should balance the benefits of breastfeeding, the mother’s need for treatment, and the potential infant risks.

👧Children & Adolescents (Under 18)

Aristada is approved for adults. Safety and efficacy are not established for patients <18 years.

👴Older Adults (65+)

Older adults are more sensitive to side effects like orthostatic hypotension, falls, EPS, and strokes. There is a boxed warning for increased mortality in dementia-related psychosis, and Aristada is **not approved** for this use.

🔬Liver Impairment

No formal dose adjustment is required, but hepatic metabolism is important; monitor for adverse effects in significant liver disease.

💧Kidney Impairment

No dosage adjustment required; metabolites are excreted renally but parent drug is hepatically cleared.

Clinical Monitoring

Adherence: Confirm injection dates and intervals at **every visit**.
Vital signs: Blood pressure (including orthostatics), pulse, temperature, and signs of infection at each visit (weekly early in treatment or after dose changes).
Weight, BMI, and waist circumference: Baseline; 8 and 12 weeks after starting or changing dose; then at least quarterly.
Fasting glucose and HbA1c: Baseline; 4 months after initiation; then annually (more often if abnormal or high risk).
Lipid panel: Baseline; 4 months after initiation; then annually (more often if abnormal).
CBC: As clinically indicated, especially if history of low WBC/ANC or unexplained infections.
EPS and tardive dyskinesia: Screen every visit; use a formal rating scale at least annually (or every 6 months in high-risk patients).
Impulse control symptoms: Ask regularly about new or increased urges to gamble, eat, spend, or have sex.
Seizure risk: Monitor closely in patients with risk factors or concomitant medications that lower seizure threshold.
Metabolic syndrome history: Reassess at least annually (personal/family history of obesity, diabetes, dyslipidemia, hypertension, or cardiovascular disease).
Mental status: Psychosis, mood symptoms, suicidality, and overall functioning at every visit.

Available Formulations

Aristada (maintenance; prefilled IM syringes): 441 mg/1.6 mL; 662 mg/2.4 mL; 882 mg/3.2 mL; 1,064 mg/3.9 mL.
Aristada Initio (one-time loading dose; prefilled IM syringe): 675 mg/2.4 mL (nanocrystal dispersion).
Injection sites: 441 mg Aristada and 675 mg Aristada Initio can be given in deltoid or gluteal muscle; higher Aristada doses are given in the gluteal muscle only.

Mechanism of Action

Aripiprazole lauroxil is a prodrug of aripiprazole. After injection, it’s slowly converted in the body to aripiprazole. Aripiprazole partially stimulates dopamine D2 and D3 receptors (partial agonist) and 5-HT1A receptors while blocking 5-HT2A receptors. This ‘dopamine system stabilizer’ profile can reduce psychotic symptoms with typically fewer metabolic and prolactin-related effects than many other antipsychotics.

Place in Treatment Algorithm

Aristada is used as a maintenance antipsychotic for adults with schizophrenia, particularly when daily oral adherence is difficult or when a long-acting formulation is preferred. It fits among the second-generation long-acting injectables as a relatively metabolically friendly option with partial-agonist properties. Choice of LAI should be individualized based on past response, side-effect profile, patient preference, and access.

Frequently Asked Questions

What is Aristada used for?

Aristada (aripiprazole lauroxil) is a long-acting injectable antipsychotic used to treat schizophrenia in adults. It is given as an intramuscular shot every 4 to 8 weeks after you’ve shown you tolerate oral aripiprazole. It is not approved for dementia-related psychosis in older adults.

What is the difference between Aristada and Aristada Initio?

Aristada is the maintenance injection given every 4 to 8 weeks for ongoing treatment. Aristada Initio is a special one-time loading shot used only to start or re-start Aristada quickly. Aristada Initio is not meant for repeated dosing.

How long does Aristada take to work?

Aristada starts reaching helpful blood levels within about 5 to 6 days, faster when used with Aristada Initio and a one-time 30 mg oral dose of aripiprazole. Because it is long-acting, it is always started after you have tolerated aripiprazole pills, and sometimes your oral dose is continued for 21 days during the first injection cycle.

Do I still need to take pills if I’m on Aristada?

You must take oral aripiprazole at the beginning to show you tolerate it. When Aristada is started with Aristada Initio, you usually take just one 30 mg oral dose on day 1. When Aristada is started without Initio, you typically continue your usual oral aripiprazole for 21 days after the first Aristada injection. After that, many people can stop daily pills and just get the injection, but your prescriber may individualize your plan.

What are the most common side effects of Aristada?

Common side effects include akathisia (restlessness), extrapyramidal symptoms like stiffness or tremor, injection-site pain or swelling, modest weight gain, headache, and insomnia. Serious but less common risks include neuroleptic malignant syndrome, tardive dyskinesia, blood count changes, and impulse control problems such as gambling, hypersexuality, or compulsive spending.

Does Aristada cause weight gain?

Aristada can cause weight gain, and about 1 in 10 patients gain at least 7% of their body weight. However, compared with many other atypical antipsychotics, its risk of significant weight gain, high cholesterol, and high blood sugar is considered lower. Regular monitoring of weight, blood sugar, and cholesterol is still recommended.

Can I drink alcohol while on Aristada?

Alcohol is best avoided. Combining alcohol with Aristada can worsen sedation, dizziness, and judgment and increase fall risk. Heavy alcohol use can also worsen mental health symptoms and increase relapse risk.

Is Aristada safe in older adults?

In older adults with schizophrenia, Aristada can sometimes be used cautiously with close monitoring. However, like all antipsychotics, it carries a boxed warning for increased risk of death when used to treat dementia-related psychosis and is **not approved** for that purpose.

What happens if I miss my Aristada injection?

If you are late or miss an injection, your prescriber will decide if you can simply get your dose as soon as possible or if you need a supplemental dose (Aristada Initio and/or a short course of oral aripiprazole). How long you are overdue and what dose you’re on determines the plan.

Can I stop Aristada suddenly?

You should not stop Aristada on your own. Because it is long-acting, its levels fall slowly over weeks. Your symptoms might return or worsen if you stop without a plan. Always talk with your prescriber; if you want to switch or stop, they will design a safe strategy and monitor for relapse.

This medication information is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Never take medication without a prescription from a licensed healthcare provider.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists

Aripiprazole Lauroxil (Aristada, Aristada Initio)

FDA Approved 2015

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published December 1, 2025•Updated December 1, 2025•Reviewed December 1, 2025